Intelligent Bio Solutions announced the broadening of the intellectual property portfolio of its wholly owned subsidiary, Intelligent Fingerprinting Limited, with the grant of a new European patent with unitary effect for its ground-breaking DSR-Plus Cartridge Reader. This latest achievement follows the successful protection of the same technology in the United Kingdom and marks another significant milestone in the Company’s expansion and protection of its intellectual property. Harry Simeonidis, President and CEO at Intelligent Bio Solutions, commented, “The grant of the European patent is a testament to the ingenuity and hard work of our team. It fortifies our intellectual property portfolio and paves the way for our expansion into the European market. We are excited about the prospects of bringing our innovative technology to more organizations and contributing to safer and healthier workplaces across Europe.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader
- Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC
- Intelligent Bio Solutions files to sell 6.78M shares of common stock for holders
- Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
- Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules